Skip to main content

Table 1 Baseline characteristics of the study population

From: Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study

 

Total

T2D PRS

Low

Intermediate

High

Very high

P value

0–19th percentile

20–79th percentile

80–98th percentile

99th percentile

(n = 345,217)

(n = 69,070)

(n = 207,192)

(n = 65,505)

(n = 3450)

Demographics & physical measurement

      

Age (years)

56.1 ± 8.0

56.2 ± 7.9

56.0 ± 8.0

56.0 ± 8.0

55.8 ± 7.9

< 0.001

Male

153,959 (44.6)

30,870 (44.7)

92,409 (44.6)

29,127 (44.5)

1553 (45.0)

0.809

Systolic blood pressure (mmHg)

140.2 ± 19.6

139.4 ± 19.7

140.2 ± 19.6

141.0 ± 19.6

142.1 ± 19.3

< 0.001

Diastolic blood pressure (mmHg)

82.5 ± 10.6

82.0 ± 10.6

82.5 ± 10.6

83.0 ± 10.6

83.7 ± 10.5

< 0.001

BMI (kg/m2)

27.3 ± 4.7

26.9 ± 4.5

27.3 ± 4.7

27.7 ± 4.8

28.3 ± 5.1

< 0.001

Waist circumference (cm)

89.8 ± 13.3

88.7 ± 13.1

89.8 ± 13.3

90.8 ± 13.4

92.5 ± 13.6

< 0.001

Townsend deprivation index

− 1.62 ± 2.90

− 1.65 ± 2.89

− 1.62 ± 2.89

− 1.61 ± 2.91

− 1.53 ± 2.87

0.003

Income level

     

< 0.001

 Less than 18,000£

61,532 (20.6)

11,952 (20.0)

37,084 (20.7)

11,858 (21.0)

638 (21.6)

 

 18,000 to 30,999£

76,307 (25.6)

15,166 (25.4)

45,831 (25.6)

14,556 (25.8)

754 (25.5)

 

 31,000 to 51,999£

80,527 (27.0)

16,135 (27.0)

48,344 (27.0)

15,237 (27.0)

811 (27.4)

 

 52,000 to 100,000£

63,331 (21.2)

13,046 (21.9)

37,916 (21.2)

11,740 (20.8)

629 (21.2)

 

 Greater than 100,000£

16,347 (5.5)

3404 (5.7)

9748 (5.4)

3067 (5.4)

128 (4.3)

 

Lifestyle and metabolic health

      

Lifestyle habits

     

< 0.001

 Favorable

182,991 (55.0)

38,009 (57.1)

109,760 (55.0)

33,562 (53.2)

1660 (50.2)

 

 Intermediate

111,276 (33.4)

21,769 (32.7)

66,812 (33.5)

21,512 (34.1)

1183 (35.8)

 

 Unfavorable

38,450 (11.6)

6805 (10.2)

23,110 (11.6)

8069 (12.8)

466 (14.1)

 

Number of metabolic syndrome components

     

< 0.001

 0 component

42,022 (14.0)

9652 (16.0)

25,187 (14.0)

6889 (12.1)

294 (9.8)

 

 1 component

93,323 (31.1)

20,157 (33.5)

56,053 (31.1)

16,326 (28.7)

787 (26.3)

 

 2 components

81,314 (27.1)

15,980 (26.6)

48,955 (27.2)

15,619 (27.4)

760 (25.4)

 

 3 or more components

83,448 (27.8)

14,390 (23.9)

49,761 (27.7)

18,142 (31.8)

1155 (38.6)

 

Laboratory findings

      

HbA1c (%)

5.4 ± 0.6

5.4 ± 0.5

5.4 ± 0.6

5.5 ± 0.6

5.6 ± 0.8

< 0.001

Fasting plasma glucose (mg/dL)

91.7 ± 20.6

90.4 ± 17.1

91.6 ± 20.3

93.3 ± 23.9

96.0 ± 30.3

 

estimated GFR (ml/min/1.73m2)

79.0 ± 14.0

78.9 ± 13.8

79.0 ± 14.0

79.2 ± 14.2

79.4 ± 14.5

< 0.001

Total cholesterol (mg/dL)

223.7 ± 42.9

223.9 ± 42.0

223.7 ± 42.9

223.5 ± 43.8

223.3 ± 45.6

0.168

Triglyceride (mg/dL)

154.5 ± 90.0

147.4 ± 85.4

154.3 ± 89.6

161.8 ± 94.4

171.0 ± 100.4

< 0.001

HDL-cholesterol (mg/dL)

56.6 ± 14.7

57.6 ± 14.8

56.7 ± 14.7

55.6 ± 14.5

54.3 ± 14.6

< 0.001

LDL-cholesterol (mg/dL)

140.1 ± 32.8

139.9 ± 32.2

140.1 ± 32.8

140.3 ± 33.4

140.5 ± 34.3

0.014

Baseline major comorbidity

      

Type 2 diabetes

11,372 (3.5)

1274 (1.9)

6646 (3.4)

3210 (5.2)

242 (7.5)

< 0.001

Dyslipidemia

48,196 (14.0)

8461 (12.2)

28,774 (13.9)

10,343 (15.8)

618 (17.9)

< 0.001

Hypertension

90,707 (26.3)

16,180 (23.4)

54,454 (26.3)

18,926 (28.9)

1147 (33.2)

< 0.001

Chronic lung disease

49,037 (14.2)

9266 (13.4)

29,629 (14.3)

9618 (14.7)

524 (15.2)

< 0.001

Chronic kidney disease

4114 (1.2)

732 (1.1)

2484 (1.2)

834 (1.3)

64 (1.9)

< 0.001

Chronic liver disease

3446 (1.0)

635 (0.9)

2032 (1.0)

730 (1.1)

49 (1.4)

< 0.001

Cancer

40,497 (11.7)

8171 (11.8)

24,219 (11.7)

7711 (11.8)

396 (11.5)

0.877

Charlson comorbidity index

0.48 ± 0.86

0.46 ± 0.85

0.48 ± 0.86

0.51 ± 0.88

0.54 ± 0.90

< 0.001

  1. Data are n (%) or mean (SD)
  2. BMI: body-mass index; HDL: high-density lipoprotein; LDL: low-density lipoprotein; T2D: type 2 diabetes; PRS: polygenic risk score